US Patent Issued to DIABETES-FREE on Aug. 25 for "Antagonistic anti-human CD40 monoclonal antibodies" (Dutch Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,929, issued on Aug. 25, was assigned to DIABETES-FREE INC. (New York).

"Antagonistic anti-human CD40 monoclonal antibodies" was invented by Anton Egbert Peter Adang (Utrecht, Netherlands) and Mark De Boer (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure concerns antibodies that bind and antagonize CD40. These antibodies are particularly useful to inhibit immune responses and treat auto-immune diseases."

The patent was filed on May 12, 2022, under Application No. 17/742,702.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOF...